(Q35586130)

9 August 2017

1 reference

title

Pathogenesis of diabetic retinopathy and the renin-angiotensin system (English)

1 reference

9 August 2017

Pathogenesis of diabetic retinopathy and the renin‐angiotensin system (English)

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

2 April 2024

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

2 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

2 April 2024

author name string

Hideharu Funatsu

1

1 reference

9 August 2017

Hidetoshi Yamashita

2

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14622351

2 April 2024

publication date

1 November 2003

1 reference

full work available at URL

9 August 2017

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1046/j.1475-1313.2003.00134.x

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14622351

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1475-1313.2003.00134.x

2 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1475-1313.2003.00134.x

2 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Ophthalmic and Physiological Optics

2 April 2024

published in

1 reference

9 August 2017

23

1 reference

9 August 2017

6

1 reference

9 August 2017

495-501

1 reference

Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders

9 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

The pathogenesis of diabetic retinopathy: old concepts and new questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Blood pressure control and diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

The 14-year incidence of visual loss in a diabetic population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

The retinal renin-angiotensin system: implications for therapy in diabetic retinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1475-1313.2003.00134.X

21 January 2018

Diabetic retinopathy

3

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Blood pressure and retinopathy in type I diabetes

2 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Modulation of the renin-angiotensin system and retinopathy

2 April 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus

2 April 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells

2 April 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Renin, prorenin, and immunoreactive renin in vitreous fluid from eyes with and without diabetic retinopathy

2 April 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Angiotensin levels in the eye

2 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Relationship between vascular endothelial growth factor and interleukin-6 in diabetic retinopathy

2 April 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes

2 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Hypertension and diabetic retinopathy--what's the story?

2 April 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Oxidative stress and diabetic vascular complications

2 April 2024

20

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study

2 April 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes

2 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

2 April 2024

Diabetic retinopathy

25

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Protein kinase C activation and the development of diabetic complications

2 April 2024

26

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Retinal neovascularization is prevented by blockade of the renin-angiotensin system

2 April 2024

29

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Expression and localization of angiotensin II type 1 receptor mRNA in rat ocular tissues

2 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells

2 April 2024

32

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Effect of antihypertensive treatment on blood-retinal barrier permeability to fluorescein in hypertensive Type 1 (insulin-dependent) diabetic patients with background retinopathy

2 April 2024

34

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

2 April 2024

38

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Recent progress in advanced glycation end products and diabetic complications

2 April 2024

41

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells

2 April 2024

42

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

Hyperglycemic pseudohypoxia and diabetic complications.

2 April 2024

43

1 reference

https://api.crossref.org/works/10.1046/J.1475-1313.2003.00134.X

2 April 2024

Identifiers

1 reference

9 August 2017

1 reference